Pathophysiology of thrombotic APS: Where do we stand?

Lupus

Volumn 21, Issue 7, 2012, Pages 704-707

  De Groot, P G ^a   Urbanus, R T ^a   Derksen, R H W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

2 glycoprotein I; Anticardiolipin antibodies; LRP8

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOSIS;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; HUMANS; THROMBOSIS;

EID: 84861556768     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312438631     Document Type: Conference Paper

References (32)

1. Miyakis S, Lockshin MD, Atsumi D, et al. International consensus statement on an update of the preliminary classification criteria for antiphospholipid syndrome (APS). J Thromb Haemostas. 2006 ; 4: 295-306
2. de Groot PG. Derksen RHWM Pathophysiology of the antiphospholipid syndrome. J Thromb Haemostas. 2005 ; 3: 1854-1860
3. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003 ; 101: 157-162
4. Pierangeli SS, Chen PP, Raschi E, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost. 2008 ; 34: 236-250
5. Arad A, Proulle V, Furie RA, Furie BC, Furie B. {Beta}2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011 ; 117: 3453-3459
6. Iverson GM, Victoria EJ, Marquis DM. Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Proc Natl Acad Sci U S A. 1998 ; 95: 15542-15546
7. de Laat B, Derksen RHWM, van Lummel M, Pennings MT, de Groot PG. Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change. Blood. 2006 ; 107: 1916-1924
8. Reddel SW, Wang YX, Sheng YH, Krilis SA. Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources. J Autoimmun. 2000 ; 15: 91-96
9. Vega-Ostertag M, Liu X, Kwan-Ki H, Chen P, Pierangeli S. A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br J Haematol. 2006 ; 135: 214-219
10. Sène D, Piette JC, Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev. 2008 ; 7: 272-277
11. van Os GM, Meijers JC, Aǧar C, et al. Induction of auto-antibodies against β(2)-glycoprotein I in mice by protein H of Streptococcus pyogenes. J Thromb Haemostas. 2011 ; 9: 2447-2456
12. Lieby P, Soley A, Knapp AM, et al. Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals. Blood. 2003 ; 102: 2459-2465
13. Fleming SD, Egan RP, Chai C, et al. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol. 2004 ; 173: 7055-7061
14. McIntyre JA, Wagenknecht DR. Antiphospholipid antibodies and renal transplantation: a risk assessment. Lupus. 2003 ; 12: 555-559
15. Fleming SD, Pope MR, Hoffman SM, et al. Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. J Immunol. 2010 ; 185: 6168-6178
16. de Laat B, Derksen RHWM, van Lummel M, Pennings MT, de Groot PG. Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change. Blood. 2006 ; 107: 1916-1924
17. Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine- dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem. 1998 ; 273: 29272-29277
18. Agar C, de Groot PG, Mörgelin M, et al. {beta}2-glycoprotein I: a novel component of innate immunity. Blood. 2011 ; 117: 6939-6947
19. Abdel-Monem H, Dasgupta SK, Le A, Prakasam A, Thiagarajan P. Phagocytosis of platelet microvesicles and beta2- glycoprotein I. Thromb Haemostas. 2010 ; 104: 335-341
20. Cucnik S, Kveder T, Ulcova G, et al. The avidity of anti-beta2- glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 2011 ; 20: 1166-1171
21. Tripodi A, de Groot PG, Pengo V. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J Intern Med. 2011 ; 270: 110-122
22. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992 ; 117: 303-308
23. Gris JC, Bouvier S, Molinari N, et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood 2011; in press.
24. de Groot PG, Raschi E, McCrae KR, Pierangeli SS, Vlachoyiannopoulos PG, Urbanus RT. What are the target cells and receptors recognized by antiphospholipid antibodies? In: Erkan D and Pierangeli SS (eds), Antiphospholipid Syndrome: Insights and Highlights from the 13th International Congress on Antiphospholipid Antibodies, in press.
25. de Groot PG, Meijers JC. β(2)-Glycoprotein I: evolution, structure and function. J Thromb Haemost. 2011 ; 9: 1275-1284
26. Satta N, Kruithof EK, Fickentscher C, et al. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood. 2011 ; 117: 5523-5531
27. Pierangeli SS, Vega-Ostertag ME, Raschi E, et al. Toll-like receptor and antiphospholipid mediated thrombosis: In vivo studies. Ann Rheum Dis. 2007 ; 66: 1327-1333
28. Doring Y, Hurst J, Lorenz M, et al. Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology. 2010 ; 215: 230-241
29. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 2009 ; 114: 3074-3083
30. Urbanus RT, Pennings MT, Derksen RH, de Groot PG. Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'. J Thromb Haemost. 2008 ; 6: 1405-1412
31. Romay-Penabad Z, Aguilar-Valenzuela R, Urbanus RT, et al. Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood. 2011 ; 117: 1408-1414
32. Aǧar C, de Groot PG, Marquart JA, Meijers JC. Evolutionary conservation of the lipopolysaccharide binding site of β2-glycoprotein I. Thromb Haemost. 2011 ; 106: 1069-1075